PYXS Smart Money
Pyxis Oncology, Inc.
1W: +0.0%
1M: -36.5%
3M: -37.0%
YTD: +60.0%
1Y: -46.8%
3Y: +12.2%
5Y: -84.0%
$1.84
+0.15 (+8.88%)
Weekly Expected Move ±12.8%
$1
$1
$2
$2
$2
Credit Risk of going bust: higher than 80% of companies Debt: 13.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.2%), Pyxis Oncology, Inc. would be worth roughly what it owes.
Total debt $17.8M against a stock market value of $116.6M.
Distance to default 2.56 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.8M (short-term plus half of long-term), stock volatility 133.2%; Altman Z'' -38.53. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down 99.2%), Pyxis Oncology, Inc. would be worth roughly what it owes.
Total debt $17.8M against a stock market value of $116.6M.
Distance to default 2.56 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.8M (short-term plus half of long-term), stock volatility 133.2%; Altman Z'' -38.53. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 202689
Institutions Holding
-2 vs prior
86.4%
Ownership
+51.85%
10
New
24
Increased
34
Reduced
10
Closed
👔 Insider Trades
9 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | GordonMD Global Investments LP | 10% owner | P-Purchase | 5,517,000 | $— | $0 | Filing |
| 2026-10-01 | GordonMD Long Biased Master Fund LP | 10% owner | P-Purchase | 5,517,000 | $— | $0 | Filing |
| 2026-10-01 | GordonMD Long Biased GP LLC | 10% owner | P-Purchase | 5,517,000 | $— | $0 | Filing |
| 2026-10-01 | Gordon Craig D | 10% owner | P-Purchase | 5,517,000 | $— | $0 | Filing |
| 2026-06-30 | Dupont Jakob | director | S-Sale | 35,000 | $3.06 | $107K | Filing |
| 2026-03-24 | Wadhane Jitendra | officer: prin fin & acct officer | A-Grant/Award | 109,461 | $— | $0 | Filing |
| 2025-04-21 | HUMPHREY RACHEL | director | S-Sale | 13,896 | $1.03 | $14K | Filing |
| 2025-04-17 | HUMPHREY RACHEL | director | S-Sale | 200 | $0.97 | $194 | Filing |
| 2025-04-14 | HUMPHREY RACHEL | director | S-Sale | 1,400 | $0.97 | $1K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| GordonMD Global Investments LP | 10,024,909 | $30M | +5,903,039 | 2026-06-30 | Filing |
| Pfizer Inc | 7,032,770 | $19M | — | 2026-06-30 | Filing |
| Laurion Capital Management LP | 4,900,888 | $15M | -96,445 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,075,997 | $6M | +42,487 | 2026-06-30 | Filing |
| Atle Fund Management AB | 966,459 | $3M | +769,423 | 2026-06-30 | Filing |
| BlackRock, Inc. | 867,934 | $3M | +79,095 | 2026-06-30 | Filing |
| Palo Alto Investors LP | 864,277 | $3M | -146,233 | 2026-06-30 | Filing |
| MARSHALL WACE, LLP | 830,544 | $2M | +476,127 | 2026-06-30 | Filing |
| RENAISSANCE TECHNOLOGIES LLC | 772,232 | $2M | -116,448 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 591,849 | $2M | -6,272 | 2026-06-30 | Filing |
| Woodline Partners LP | 523,999 | $2M | +523,999 | 2026-06-30 | Filing |
| 683 Capital Management, LLC | 459,367 | $1M | -436,896 | 2026-06-30 | Filing |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 428,606 | $1M | -32,391 | 2026-06-30 | Filing |
| Longaeva Partners L.P. | 353,582 | $1M | -149,632 | 2026-06-30 | Filing |
| Decheng Capital LLC | 326,810 | $984K | — | 2026-06-30 | Filing |
| VANGUARD FIDUCIARY TRUST CO | 302,986 | $912K | +2,089 | 2026-06-30 | Filing |
| JANE STREET GROUP, LLC | 290,090 | $873K | -14,369 | 2026-06-30 | Filing |
| STATE STREET CORP | 248,837 | $749K | — | 2026-06-30 | Filing |
| MILLENNIUM MANAGEMENT LLC | 233,004 | $701K | -164,621 | 2026-06-30 | Filing |
| UBS Group AG | 155,217 | $467K | -98,907 | 2026-06-30 | Filing |